Accordingly, we extended this analytical framework of MT2A to investigate the pathological relevance of hypoxia-responsive PKM2 in breast cancer with the human breast cancer scRNA-seq dataset (Wu et al., 2021b) to examine the correlation between PKM2 expression patterns and tumor hypoxic status. This evidence concerns the gene MT2A and breast cancer.